跳至主要内容
临床试验/NCT03972618
NCT03972618已完成不适用

Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic

Dordt University1 个研究点 分布在 1 个国家目标入组 698 人开始时间: 2018年9月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
698
试验地点
1
主要终点
Diarrhea

研究概览

简要总结

Nathan Tintle, in conjunction with others at Dordt College including Dr. Kristin Van De Griend and undergraduate student research assistants, have agreed to collaborate with Hope College to analyze the impact of different water filter deployment strategies in schools and villages on diarrhea and other medical and economic outcomes. The distribution of the water filters will begin in September 2018 to Child Hope schools in 4 different countries (Dominican Republic, Guatemala, Honduras, and Nicaragua). In order to evaluate efficacy of alternative filter deployment strategies, filters will be distributed in 4 separate treatment arms including schools, homes, simultaneous home/school and a control group

详细描述

Nathan Tintle, in conjunction with others at Dordt College including Dr. Kristin Van De Griend and undergraduate student research assistants, have agreed to collaborate with Hope College and Sawyer Products, Inc. to analyze the impact of different water filter deployment strategies in schools and villages on diarrhea and other medical and economic outcomes. The distribution of the water filters will begin in September 2018 to Child Hope schools in 4 different countries (Dominican Republic, Guatemala, Honduras, and Nicaragua). In order to evaluate efficacy of alternative filter deployment strategies, filters will be distributed in 4 separate treatment arms:

Arm 1: Simultaneous installation of filters in schools and the villages sending children to the school Arm 2: Initial installation of the water filters in a school, with later installation in the corresponding village Arm 3: Instillation of the water filters in villages, with later installation in the corresponding school Arm 4: Control arm. No filter installation initially but, ultimately, installation of filters in both the schools and villages.

Self-reported information on filter usage and health outcomes will be collected through surveys administered to parents (in the households in the villages), teachers (in the schools) and school administrators. Data collection will occur at baseline (when filters are installed), at 2 and 8 weeks post installation. The major goal of this project is to better understand the different health impacts of each different deployment strategy on child and family wellbeing. Better understanding of these filter installation strategies will help guide us as we make filter deployment decisions to provide access to clean drinking water.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lives in selected villages and has children that attend the local school

排除标准

  • No children attending the local school

研究组 & 干预措施

School and village

Experimental

Simultaneous installation of filters in schools and the village

干预措施: Installation of water filtration system for filtering existing water source (Behavioral)

School only

Experimental

Initial installation in school only

干预措施: Installation of water filtration system for filtering existing water source (Behavioral)

Village only

Experimental

Initial installation in village only

干预措施: Installation of water filtration system for filtering existing water source (Behavioral)

Control

No Intervention

Control group. No filter installation initially.

结局指标

主要结局

Diarrhea

时间窗: 2-weeks

self-report of diarrhea

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Estudio pivotal para determinar la eficacia y seguridad de AP23573 administrado como tratamiento de mantenimiento a pacientes con sarcoma metastásico óseo o de partes blandas.
EUCTR2007-003462-18-ESARIAD Pharmaceuticals, Inc.675
进行中(未招募)
不适用
Etude de cohorte évaluant l'efficacité cliique, la tolérance et l'immunogénicité à la vaccination antigrippale pandémique chez les patients atteints de mucoviscidose et, le cas échéant, l'expression clinique de la grippe A (H1N1) et les facteurs associés à la survenue de formes sévères dans cette population. - Etude MUCOFpatients atteints de mucoviscidoseMedDRA version: 12.0Level: LLTClassification code 10011762Term: Cystic fibrosis
EUCTR2009-016662-90-FRInserm
进行中(未招募)
1 期
Etude pilote, multicentrique, évaluant l’efficacité d’un traitement anti VHC optimisé (induction par 360µg/S de PegIFN-alpha 2a + 18mg/kg/j de RBV pendant 6 mois puis en fonction de la réponse virologique à S12, allongement jusqu'à S72 de la bithérapie anti VHC, avec mesures d'accompagnement) sur la réponse virologique soutenue chez des patients VHC de génotype 1 et 4, non répondeurs et co-infectés par le VIH. - ETOCCet essai vise à étudier la réponse à un re-traitement optimisé de l’hépatite C chez des patients co-infectés VIH-VHC (génotype 1 et 4), non répondeurs aux premiers traitements pour le VHC.MedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CMedDRA version: 9.1Level: LLTClassification code 10001509Term: AIDS
EUCTR2008-000859-10-FRANRS
进行中(未招募)
不适用
ESTUDIO PARA EVALUAR LA EFECTIVIDAD DEL TRATAMIENTO DIETÉTICO CON TRIHEPTANOINA EN PACIENTES CON DEFECTOS DE LA BETA OXIDACIÓN DE LOS ÁCIDOS GRASOS DE CADENA LARGAPACIENTES CON DEFECTOS DE LA BETA OXIDACIÓN DE LOS ÁCIDOS GRASOS DE CADENA LARGA
EUCTR2007-005578-29-ESMª Luz Couce
进行中(未招募)
1 期
Etude de l’efficacité et de la tolérance, de l’injection intra prostatique de toxine botulique A, chez l’homme, dans le traitement de l’hyperplasie bénigne de prostate symptomatique. - ProtoxHBP symptomatique modérée à sévère selon le score IPSSMedDRA version: 12.1Level: LLTClassification code 10020728Term: Hyperplasia of prostate
EUCTR2010-022255-37-FRCHU de Bordeaux127